These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1280738)

  • 41. Studies on the mechanism of the cardiovascular action of central injections of histamine.
    Klein MC; Gertner SB
    Neuropharmacology; 1983 Sep; 22(9):1109-15. PubMed ID: 6138730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Omega-conotoxin increases sleep time following ethanol injection.
    Brown LM; Sims JS; Randall P; Wilcox R; Leslie SW
    Alcohol; 1993; 10(2):159-62. PubMed ID: 8442894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of diverse omega-conopeptides on the in vivo release of glutamic and gamma-aminobutyric acids.
    Newcomb R; Palma A
    Brain Res; 1994 Feb; 638(1-2):95-102. PubMed ID: 7911066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNX-111).
    Verweij BH; Muizelaar JP; Vinas FC; Peterson PL; Xiong Y; Lee CP
    Neurol Res; 1997 Jun; 19(3):334-9. PubMed ID: 9192388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biphasic blood pressure response to neuropeptide Y in anesthetized rats.
    Grundemar L; Wahlestedt C; Shen GH; Zukowska-Grojec Z; Håkanson R
    Eur J Pharmacol; 1990 Apr; 179(1-2):83-7. PubMed ID: 2364989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A consensus structure for omega-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: comparison of MVIIA, SVIB and SNX-202.
    Nielsen KJ; Thomas L; Lewis RJ; Alewood PF; Craik DJ
    J Mol Biol; 1996 Oct; 263(2):297-310. PubMed ID: 8913308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitochondrial dysfunction after experimental traumatic brain injury: combined efficacy of SNX-111 and U-101033E.
    Xiong Y; Peterson PL; Verweij BH; Vinas FC; Muizelaar JP; Lee CP
    J Neurotrauma; 1998 Jul; 15(7):531-44. PubMed ID: 9674556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central effect of endothelin on blood pressure in conscious rats.
    Ouchi Y; Kim S; Souza AC; Iijima S; Hattori A; Orimo H; Yoshizumi M; Kurihara H; Yazaki Y
    Am J Physiol; 1989 Jun; 256(6 Pt 2):H1747-51. PubMed ID: 2660598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain.
    Brose WG; Gutlove DP; Luther RR; Bowersox SS; McGuire D
    Clin J Pain; 1997 Sep; 13(3):256-9. PubMed ID: 9303259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of disulfide bridge pattern in omega-conopeptides.
    Chung D; Gaur S; Bell JR; Ramachandran J; Nadasdi L
    Int J Pept Protein Res; 1995; 46(3-4):320-5. PubMed ID: 8537186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular effects of urotensin II in anesthetized and pithed rats.
    Gibson A; Wallace P; Bern HA
    Gen Comp Endocrinol; 1986 Dec; 64(3):435-9. PubMed ID: 2879765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ziconotide. CI 1009, SNX 111.
    Drugs R D; 1999 Jan; 1(1):46-8. PubMed ID: 10565986
    [No Abstract]   [Full Text] [Related]  

  • 53. Blood pressure modulation following activation of mast cells by cationic cell penetrating peptides.
    Basheer M; Schwalb H; Shefler I; Levdansky L; Mekori YA; Gorodetsky R
    Peptides; 2011 Dec; 32(12):2444-51. PubMed ID: 21971370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioavailability of Ziconotide in brain: influx from blood, stability, and diffusion.
    Newcomb R; Abbruscato TJ; Singh T; Nadasdi L; Davis TP; Miljanich G
    Peptides; 2000 Apr; 21(4):491-501. PubMed ID: 10822104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular reflex responses after intrathecal omega-conotoxins or dexmedetomidine in the rabbit.
    Blake DW; Wright CE; Scott DA; Angus JA
    Clin Exp Pharmacol Physiol; 2003; 30(1-2):82-7. PubMed ID: 12542459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complicated central effects of endothelin on blood pressure in rats.
    Minamisawa K; Hashimoto R; Ishii M; Kimura F
    Jpn J Physiol; 1989; 39(6):825-32. PubMed ID: 2698967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasopressor effects of intracerebroventricular injections of PEC-60, a novel porcine 60-residue intestinal peptide, in the awake unrestrained male rat.
    Aguirre JA; Fuxe K; Agnati LF; Agerberth B; Mutt V
    Neurosci Lett; 1990 Oct; 119(1):129-31. PubMed ID: 2097576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxytocin causes a long-term decrease of blood pressure in female and male rats.
    Petersson M; Alster P; Lundeberg T; Uvnäs-Moberg K
    Physiol Behav; 1996 Nov; 60(5):1311-5. PubMed ID: 8916187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurex launches phase III program for SNX-111 for the treatment of chronic pain.
    AIDS Patient Care STDS; 1996 Oct; 10(5):311-2. PubMed ID: 11361532
    [No Abstract]   [Full Text] [Related]  

  • 60. Current Drug Development Overview: Targeting Voltage-Gated Calcium Channels for the Treatment of Pain.
    Antunes FTT; Campos MM; Carvalho VPR; da Silva Junior CA; Magno LAV; de Souza AH; Gomez MV
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.